Marinelli L - Search Results

1

Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers.

Tomassi S, Ieranò C, Mercurio ME, Nigro E, Daniele A, Russo R, Chambery A, Baglivo I, Pedone PV, Rea G, Napolitano M, Scala S, Cosconati S, Marinelli L, Novellino E, Messere A, Di Maro S. Tomassi S, et al. Among authors: marinelli l. Bioorg Med Chem. 2018 May 15;26(9):2539-2550. doi: 10.1016/j.bmc.2018.04.017. Epub 2018 Apr 7. Bioorg Med Chem. 2018. PMID: 29656988

2

Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.

Marinelli L, Lavecchia A, Gottschalk KE, Novellino E, Kessler H. Marinelli L, et al. J Med Chem. 2003 Oct 9;46(21):4393-404. doi: 10.1021/jm020577m. J Med Chem. 2003. PMID: 14521404

3

Human integrin alphavbeta5: homology modeling and ligand binding.

Marinelli L, Gottschalk KE, Meyer A, Novellino E, Kessler H. Marinelli L, et al. J Med Chem. 2004 Aug 12;47(17):4166-77. doi: 10.1021/jm030635j. J Med Chem. 2004. PMID: 15293989

4

Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.

Sukopp M, Schwab R, Marinelli L, Biron E, Heller M, Várkondi E, Pap A, Novellino E, Kéri G, Kessler H. Sukopp M, et al. Among authors: marinelli l. J Med Chem. 2005 Apr 21;48(8):2916-26. doi: 10.1021/jm049500j. J Med Chem. 2005. PMID: 15828830

5

Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists.

Marinelli L, Meyer A, Heckmann D, Lavecchia A, Novellino E, Kessler H. Marinelli L, et al. J Med Chem. 2005 Jun 30;48(13):4204-7. doi: 10.1021/jm040224i. J Med Chem. 2005. PMID: 15974570

6

Urotensin-II receptor ligands. From agonist to antagonist activity.

Grieco P, Carotenuto A, Campiglia P, Marinelli L, Lama T, Patacchini R, Santicioli P, Maggi CA, Rovero P, Novellino E. Grieco P, et al. Among authors: marinelli l. J Med Chem. 2005 Nov 17;48(23):7290-7. doi: 10.1021/jm058043j. J Med Chem. 2005. PMID: 16279788

7

Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as mu-opioid receptor imaging agents.

Henriksen G, Platzer S, Marton J, Hauser A, Berthele A, Schwaiger M, Marinelli L, Lavecchia A, Novellino E, Wester HJ. Henriksen G, et al. Among authors: marinelli l. J Med Chem. 2005 Dec 1;48(24):7720-32. doi: 10.1021/jm0507274. J Med Chem. 2005. PMID: 16302812

8

Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.

Di Santo R, Costi R, Roux A, Artico M, Lavecchia A, Marinelli L, Novellino E, Palmisano L, Andreotti M, Amici R, Galluzzo CM, Nencioni L, Palamara AT, Pommier Y, Marchand C. Di Santo R, et al. Among authors: marinelli l. J Med Chem. 2006 Mar 23;49(6):1939-45. doi: 10.1021/jm0511583. J Med Chem. 2006. PMID: 16539381 Free PMC article.

9

Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.

Cosconati S, Marinelli L, Lavecchia A, Novellino E. Cosconati S, et al. Among authors: marinelli l. J Med Chem. 2007 Apr 5;50(7):1504-13. doi: 10.1021/jm061245a. Epub 2007 Mar 3. J Med Chem. 2007. PMID: 17335186

10

Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design.

Limongelli V, Marinelli L, Cosconati S, Braun HA, Schmidt B, Novellino E. Limongelli V, et al. Among authors: marinelli l. ChemMedChem. 2007 May;2(5):667-78. doi: 10.1002/cmdc.200600314. ChemMedChem. 2007. PMID: 17407105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters